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LIVER TRANSPLANT ATION* 
Thomas E. Starzl, M.D., Ph.D., 
and Lawrence J. Koep, M.D. 
Two centers have accumulated the vast 
majority of the world experience in liver 
transplantation, our own and the English 
team headed by Caine and Williams, which 
works at Cambridge University and Kings 
College in London.' The British group has 
treated very few children because they rarely 
have had pediatric donors. In addition. they 
have been fearful of the growth limitation 
and cosmetic deformity inherent in long· 
term steroid therapy. Consequently. most of 
the comments and practically all of the data 
in this chapter are from the University of 
Colorado series. The potential bias in this 
parochial situation may have been partly 
compensated by eur ability to obtain accu-
rate follow-ups and analY,ses of every patient 
to January 1979. 
Two kinds of whole liver transplantation 
have been used clinically. orthotopic liver 
transplantation (liver replacement) and aux· 
iliary liver transplantation. Both will be de-
scribed. but most of this chapter will deal 
with the replacement procedure. since it has 
yielded the best - although still unsatisfac-
tory - results. The problems of an experi-
ence with auxiliary transplantation will be 
covered in this introd uction. 
Auxiliary liver Transplantation 
Auxiliary liver transplantation is the 
placement of an extra liver in some ectopic 
site such as the right paravertebral gutter. 
pelvis. or splenic fossa. This operation was 
described in dogs by C.S. Welch in 1955 and 
shortly thereafter was attempted in humans.3 
Fortner and colleagues~ recently compiled a 
"The work was supported by research grants from the 
Veterans Administration: by grant numbers AM-17260 
and AM-07772 from the National Institutes of Health; 
by grant numbers RR-00051 and RR-00069 from the 
General Clinical Research Centers Program of the Div\· 
sion of Research Resources. National Institutes of 
Health. 
total of 43 clinical trials contributed from 
many centers. including 4 from the Univer-
sity of Colorado and 7 from their own insti-
tution. There had been only one unqualified 
success. that being the 51/z-year postopera-
tive survival of a child with biliary atresia in 
whom the auxiliary liver was still function-
ing well. All of the other patients died 
within a few weeks or months postopera· 
tively. No difference between pediatric and 
adult recipients was seen in these cases. 
Both the appeal and the disadvantages of 
auxiliary liver transplantation derive from 
retention of the diseased native liver.:! By not 
removing the diseased organ, some technical 
problems are avoided.- In addition. the recip-
ient is not placed totally and immediately at 
the mercy of function of the homograft. This 
may not be a significant theoretic benefit in 
patients with truly end-stage liver disease. 
but in children with biliary atresia. many 
synthetic and other metabolic functions are 
still quite adequate at the time of transplan-
tation. Unfortunately. one infant with 
Crigler-Najjar syndrome whose liver was 
functioning normally except for the inability 
to conjugate bilirubin died when the blood 
supply to the cadaveric auxiliary liver clot-
ted several days after auxiliary transplanta-
tion. Such technical problems result from 
the awkward revascularization procedures 
necessitated by placement of an extra organ 
in an abdomen that is frequently already 
overcrowded. The most natural place for a 
new organ is the liver fossa vacated by hest 
hepatectomy. 
The extent to which function remains in 
the native liver influences the fate of an 
auxiliary organ. When two functioning 
livers coexist. they compete for so-called 
hepatotrophic substances that are normally 
brought to the liver via the portal vein from 
splanchnic organs. The most important of 
these factors is endogenous insulin. The 
removal of hepatotrophic substances by the 
organ with first access to portal blood jeopar-
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Figure 44-1 Auxiliary liver transplantation in a pa-
tient with cirrhosis. Note that the transplant in the right 
paravertebral gutter was given a double blood supply 
and that the venous component was from the non-
hepatic splanchnic bed. Homog.raft portal inflow was-
assu red by the portal hypertension caused by ci rrhosis. 
(From Starzl. T. E.: Experience in Hepatic Transplanta-
tion. Philadelphia. W. B. Saunders Company. 1969.) 
dizes the structure, function, and capacity 
for regeneration of the other liver. Although 
this aspect of hepatic physiology is complex, 
the practical conclusion is that optimally 
vascularized auxiliary homografts must be 
given a portal inflow from splanchnic 
sources. The operation in Fortner's long-
surviving patient met this criterion, being in 
principle like that shown in Figure 44-1. 
In the future, the most important use of 
auxiliary liver transplantation may be to tide 
patients over a bout of fulminant hepatic 
failure, allowing time for the acutely dam-
aged native liver to regenerate. The concept 
has been validated in controlled animal ex-
periments and even in partially successful 
clinical trials at our institution, but long-
tt 'rm ~urvival of such patients has not yet 
bee I I au:omplished. 
Orthotopic Liver Transplantation 
Cannon first reported unsuccessful ortho-
topic liver transplantation in animals. The 
technical feasibility of the procedure was 
established by work at the Peter Bent 
Brigham Hospital and at the University of 
Colorado.s The recipient liver is removed 
and the donor liver inserted in its place. 
In principle, the operation is simple, re-
quiring reconnection of the vena cava above 
and below the liver and anastomosis of the 
hepatic artery and portal vein (Fig. 44-2). 
Biliary tract retonstruction is a critical detail, 
as will be mentioned later. The orthotopic 
operation has been the most widely used and 
successful kind of liver transplantation. 
It is interesting that two of our long-term 
survivors after liver replacement (9 years 
and 1 year) had unsuspected incidental 
tumors in their livers, which were removed 
because of biliary atresia and alpha l -
antitrypsin deficiency. The first was a hepa-
toma and the second a hepatoblastoma. Nei-
ther has recurred. Three other children (two 
with biliary atresia and one with tyrosin-
emia) who had similar incidental hepatomas 
died early postoperatively. Such a high in-
cidence of incidental neoplasia in our series 
of 74 pediatric cases of liver replacement 
(see succeeding sections and Table 44-1) is 
an extra notation in favor of recipient hepa-
tectomy and orthotopic liver transplantation 
as opposed to the auxiliary grafting proce-
dure. 
Figure 44-2 Completed orthotopiC liver transplan-
tation. with duct·ta-duct biliary reconstruction. (From 
Stanl. T. E.: Experience in Hepatic Transplantation. 
Philadelphia, W. B. Saunders Company, 1969.) 1 
------------____ .. 1 .. 1 __ 
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TABLE 44-1 INDICATIONS FOR ORTHOTOPIC LIVER TRANSPLANTATION AND 
OUTCOME IN 74 PEDIATRIC CASES (1963-1977) 
Number of Survival at Duration of Survivor 
Diagnosis Examples 1 Yea,· Alive Now Follow-up (Months) 
Biliary atresia 48 16 8 12. 21. 52. 65. 72. 
84.91. 109 
Chronic aggressive hepatitis 12 4 3 16.51.60 
Alpha, -antitrypsin deficiency 4 3 2 12. 26 
Hepatoma 3 2t 0 
Wilson's disease 2 2 1 95 
Neonatal hepatitis 2 1 1 26 
Congenital biliary cirrhosis 1 1 1 81 
Tyrosinemia 1 0 0 
Type IV glycogen storage disease 1 0 0 
Total 74 29 16 
"Deaths after 1 year were at 12. 13. 13'/2. 14. 16'/2. 17. 20. 23. 26. 28. 30. 41 and 72 months. Follow-up on all cases 
to January 1979. 
t Both late deaths due to recurrent hepatoma. 
BASIC SCIENCE 
The unique and pervasive element of liver 
transplantation. however. is immunologic. 
The liver. like other tissues and organs. 
evokes a recipient reaction to its alien pres-
ence. Classically. the response that is termed 
rejection was said to be a pure expression of 
cell-mediated immunity. the kind that is 
responsible for delayed hypersensitivity 
(like the tuberculin skin test) reactioris. Later 
it -became clear that rejection represented a 
wide-ranging immunologic assault in which 
subpopulations of lymphocytes (T and B 
cells among others) played out their roles 
and in which humoral antibodies frequently 
participated. The explosion of new knowl-
edge in immunology has not delineated the 
exact mechanisms of rejection. It has only 
made it clear that rejection is an immun-
ologic event of great complexity. 
Within a short time after it became techni-
cally feasible to perform hepatic transplanta-
tion. the manifestations of untreated rejec-
tion in dogs were delineated.3 The 
homografts functioned normally for a few 
days. The recipients then became jaundiced, 
and serum transaminase levels increased 
markedly. Histopathologically, the livers 
were overrun with mononuclear cells. and 
various degrees of necrosis presaged death 7 
to 10 days postoperatively. By electron mi-
croscopy. lymphoid cells could be seen to 
squeeze through cell junctions of the endo-
thelial lining of the microvasculature and to 
work their way toward hepatocytes. There 
were declines in hepatic blood flow during 
this time. Such changes were variably ob-
served in other species. In particular, the pig 
was shown to have an especially weak and 
late rejection response that often was not 
fatal. I. 3 
Poor understanding of the details of rejec-
tion did not deter research to prevent or 
control the process. In 1963 and 1964 the 
cytotoxic drug azathioprine was shown in 
dogs to permit long survival after liver re-
placement.3 One dog from that original Col-
- orada series lived for almost 12 years:- Later. 
similar results were accomplished in our 
laboratories with antilymphocyte serum 
(ALS) or its globulin derivative (ALG). Even-
tually. such work helped in evolving multi-
ple agent programs to prevent and control 
rejection. Generally. these were tested clini-
cally in the simpler clinical circumstances of 
renal transplantation and applied secondari-
ly to liver patients. 
CLINICAL ASPECTS OF LIVER 
REPLACEMENT 
Indications for Operation 
When orthotopic liver transplantation was 
first contemplated clinically. it was thought 
that one highly justifiable use would be for 
the treatment of primary hepatic malignan-
cies that could not be resected with conven-
tional techniques but that had not yet spread 
beyond the liver. The logic was flawed. 
There was the overwhelming recurrence rate 
of 85 per cent in our combined adult and 
pediatric series5 and a 70 per cent rate in the 
English experience from Cambridge Univer-
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sity and Kings College. London.' Three of 
our early pediatric recipients were treated 
for hepatoma (Table 44-1). One died of mas-
sive metastases after 143 days. and the two 
others succumbed to tumor recurrence short-
ly after the first postoperative year. Although 
an occasional cure of malignancy has been 
obtained."s today we discourage parents 
who solicit such treatment for their chil-
dren. 
At the University of Colorado. 74 pediatric 
patients (18 years or younger) had liver 
transplantation performed between March 
1963 and December 1977 (Table 44-1). Thus. 
a minimum potential 1 year follow-up is 
available in every case. All patients had 
chronic liver disease. 
Biliary atresia was the most common diag-
nosis. accounting for almost twice as many 
cases as all other diseases combined. Chron-
ic aggressive hepatitis was the next most 
common indication. Eight patients had in-
born errors of metabolism. including alpha- I -
antitrypsin deficiency, Wilson's disease. 
tyrosinemia, and type IV glycogen disease. It 
has been established that the enzyme speci-
ficity and protein synthetic phenotypes of 
liver homografts remain permanently those 
of the donor.3• 5 Thus any liver-based inborn 
error of metabolism is potentially curable 
with liver transplantation. 
The appropriate time to recommend liver 
transplantation requires judgment. The pre-
dictable and tragic course of victims of bili-
ary atresia usually makes it easy to proceed 
relatively early, but here also long survival 
may be possible, particularly if a partially 
successful porticoenterostomy has been per-
formed. Moreover, it is a technical ad~antage 
if the potential recipient can be allowed to 
grow and live to be a year or older in other 
than a moribund state. 
Practically all of the other nonneoplastic 
liver diseases for which liver transplantation 
could be the last resort have less predictable 
natural histories. Consequently, these pa-
tients tend to be operated on late. A reason-
able general rule is to proceed with the 
advent of social invalidism. This means the 
inability to continue education or to work 
because of encephalopathy or other reasons. 
The need for chronic hospitalization for a 
variety of complications is a sure sign that 
the end is approaching. Unfortunately, fur-
ther decline from this point onward tends to 
occur so rapidly that many prospective re-
cipients have been lost when a donor could 
not be found promptly, 
Tissue typing has played virtually no role 
in directing patient selection. partly because 
the need of recipients becomes so great that 
they usually cannot wait for a well-matched 
organ. Even the presence of preformed an-
tidonor cytotoxic antibodies in the recipient 
serum does not contraindicate operation. 
Such hostile preformed antibodies, which 
immediately destroy kidney grafts, have not 
had adverse effects on liver transplants. I. :; 
We strive for red blood cell group compati-
bility except in situations of extreme urgen-
cy, although the anti donor red blood cell 
isoaggultinins have usually not had adverse 
effects on the transplanted liver.5 
Surgical Considerations 
1n recent years all cadaveric livers have 
been obtained from "brain dead" donors 
whose circulation is supported until organ 
removal. After dissection, the grafts are 
abruptly cooled by infusion with a cold 
electrolyte solution containing low molecu-
lar weight dextran. If preservation is neces-
sary'for many hours, a final flush with spe-
cial solutions increases the safety factor and 
has permitted the transport of livers that 
were excised in distant cities." 5 
During the two vena caval anastomoses in 
the recipient, a slow infusion of intraportal 
chilled solution is resumed to float out air 
bubbles trapped in the graft. Failure to ob-
serve this precaution has resulted in lethal 
air embolization at the time of restoration of 
hepatic blood flow.5 The usual order of vas-
cular anastomoses is suprahepatic vena 
cava, infrahepatic vena cava, portal vein, 
and hepatic artery. If these can be done 
quickly, all are completed before the hepatic 
blood supply is restored. The liver is revas-
cularized with portal blood only if more 
than 60 to 90 minutes are invested in the first 
three anastomoses or if the recipient has an 
unstable circulatory state from combined 
caval and portal obstruction. Under these 
circumstances, the hepatic artery is recon-
structed when the situation has stabilized. If 
the portal anastomosis is a good one, there 
usually is prompt transhepatic decompres-
sion of portal hypertension, allowing ade-
quate hemostasis despite continuing coagu-
lation abnormalities. 
Accurate timing between the donor and 
recipient teams is essential to avoid unnec-
essary ischemia of the graft on one hand or 
excessively prolonged obstruction of the re-
cipient caval and portal systems on the 
other. A completed orthotopic liver trans-
plantation is shown in Figure 44-2. The 
details of the procedure have been fully 
described elsewhere." 3. ~ Some special com-
ments about the operation in pediatric recip-
ients follow. 
Removal of the diseased liver usually is 
much easier in children than in adults, even 
after multiple previous operations, including 
Kasai porticoenterostomies. The extensive-
ness of venous collaterals caused by portal 
hypertension is less in infants and children 
than in adults with cirrhosis, making it often 
possible to perform the operation with 500-
or 1000-ml blood transfusions in spite of 
serious coagulation defects. The mobility of 
the costal margins usually allows the proce-
dure to be performed through a transverse 
abdominal incision without a thoracic exten-
sion. The younger the patient, the more 
pronounced are these advantages. 
Unfortunately, there have been disadvan-
tages to smallness. In evaluating the causes 
of death in our first 141 cases of adults and 
Rgure 44-3 Techniques of 
biliary duct reconstruction used 
for most of the transplantation 
recipients in the Colorado series. 
A, Cholecystoduodenostomy. 
This operation is no longer per-
formed. B. Cholecystojejunos-
tomy. C. Choledochojejunos-
tomy after removal of gallblad-
der. D. Choledochocholedo-
chostomy. Note that the T-tube 
is placed. if possible. in recipient 
common duct. (From Surg. 
Gynecol. Obstet.. 142 :487-505, 
.. '" 1976.) 
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children, the major impact of technical acci-
dents was obviousI~ including vascular 
thromboses. which were particularly com-
mon in patients with biliary atresia. Con-
sequently, we have recently used microsur-
gical techniques, particularly for the hepatic 
artery and portal vein. The essential in-
gredients are loop magnification glasses, 
fine sutures (6-{) to 8-0). and fine needle 
holders and pickups. 
In our early experience. there was an ap-
palling 35 per cent incidence of obstruction 
of or bile fistula from the reconstructed bili-
ary tract. The obstructions frequently were 
ascribed to rejection and not diagnosed until 
autopsy. The most common technique then 
used was cholecystoduodenostomy after li-
gation of the common duct (Fig. 44-JA). 
Even with seemingly satisfactory biliary 
drainage, the patients had an extraordinarily 
high incidence of bacteremia, which was 
probably caused by repeated contamination 
through the anastomosis. 
We abandoned cholecystoduodenostomy 
"c -
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in 1974 and now do duct-to-duct anasto-
moses over a T tube (Fig. 44-30) except in 
patients with biliary atresia. Reasonable op-
tions for treatment of that disease are chole-
cystojejunostomy (Fig. 44-3B) and choledo-
chojejunostomy (Fig. 44-3C) , using an 
l8-inch Roux limb. With cholecystojejunos-
tomy. about a third of recipients develop 
obstruction of the cystic duct, but cholecys-
tectomy and conversion to choledochoen-
terostomy (Fig. 44-3B. C) has proved to be 
easy. It may be safer to anastomose secon-
darily such a dilated common duct to bowel 
than to attempt this with the tiny common 
duct of a normal infant liver. Primary chole-
dochocholedochostomies and choledochoje-
junostomies are drained through the wound, 
but this is not necessary with cholecystoje-
junostomies. Formation of a Roux limb is 
hazardous in heavily immunosuppressed re-
cipients. Seven patients in our combined 
adult-pediatric series of 141 have died from 
later perforations at the enteroenterostomy.s 
An important component of the reforms 
instituted several years ago was constant 
postoperative suspicion of the biliary recon-_ 
struction. Postoperative jaundice, fever, or 
abdominal pain has become a signal for 
cholangiography (usually T tube or transhe-
patic). re-exploration, or often both. 
Anomalies have been common in children 
with biliary atresia. The most serious, which 
we have seen four times. was a combination 
of a preduodenal portal vein, an hepatic 
artery originating from the superior mesen-
teric artery, absent inferior vena cava, and 
malrotation of the gut.3 We considered such 
cases to be untreatable until success was 
obtained in a child who is now 4 years and 4 
months postoperative. Other less ominous 
donor and recipient anomalies and their 
technical implications are described else-
where.3 
In many patients, splenectomy is advis-
able because of hypersplenism or massive 
splenomegaly. Failure to remove the spleen 
may lead to an inability to give the important 
drug azathioprine in the postoperative 
period because of persistent leukopenia. 
It is essential that hemostasis be metic-
ulous before closing. Since full correction 
of clotting abnormalities may require hours 
or even days, the main recourse is mechani-
cal hemostasis to which intravenous infu-
sions of platelets and fresh frozen plasma 
may be added. Persistent hemorrhage is 
often from the back of one of the vascular 
anastomoses. VenGUS infarction of the right 
adrenal gland may be responsible, since the 
right adrenal vein must be sacrificed during 
the recipient hepatectomy.:I Adrenalectomy 
is the only way to control this kind of bleed-
ing, which manifests as a diffuse ooze be-
hind the right lobe of the liver. 
POSTOPERATIVE MANAGEMENT 
There are two fundamental guidelines. 
The first is to prevent or control rejection by 
combination drug therapy, which is begun 
on the day of operation and continued in-
definitely thereafter. The second is to be sure 
that postoperative hepatic dysfunction is ac-
tually due to rejection. Numerous technical 
surgical pitfalls were mentioned earlier, of 
which biliary tract problems were the most 
important and treatable. Besides ruling out 
biliary complications with cholangiography, 
frequent liver biopsies can strengthen the 
diagnosis of rejection, or they can point out 
other possibilities such as isenemic or drug 
injury and hepatitis. In short, the -patient 
should be approached unprejudicially as a 
diagnostic problem . 
If other factors are ruled out, the patient's 
survival (short of retransplantation) depends 
upon control of rejection. Azathioprine 
(which can be replaced with cyclophospha-
mide) and prednisone are used. I • 3 • 4 • 5 As 
much azathioprine is given as is possible 
without causing bone marrow depression 
and leukopenia. The prednisone dose may 
be varied to treat crises. We recommend, in 
addition, a 2- to 3-week course of intraven-
ous ALG. Although these double or triple 
agent regimens usually can prevent or re-
verse rejection, the price of prolonged high-
dose steroid therapy is all too frequently an 
inexorable decline of the patient's health 
capped in the end by a fatal infection. 
To provide better immunologic control 
with less steroid treatment, we have in the 
last year used thoracic duct drainage as a 
lymphocyte-depleting immunosuppressive 
adjunct, usually starting on the day of trans-
plantation and continuing for 1 tD 3 months.5 
It is too early to judge the value of this 
procedure or to preclude the possibility that 
its greatest effectiveness will be for pretreat-
ment in advance of transplantation. The next 
major improvement in survival will likely 
depend on improvement in the double and 
triple drug programs that have been so dan-
gerous in the past. 
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RESULTS 
The outcome in 74 pediatric patients treat-
ed 1 to almost 16 years ago is summarized in 
Table 4+-1. Twenty-nine (40 per cent) of the 
74 recipients lived for at least 1 year after 
operation, and 16 (22 per cent) still survive, 
all but 4 with follow-ups of more than 2 
years. Ten of the 16 long survivors have 
follow-ups of at least 4 years with a max-
imum of 9 years. The 13 late deaths occurred 
from 1 to 6 years postoperatively at the exact 
times annotated in a footnote in Table 44-1. 
It has been documented that many of the 
patients who died after 1 year could have 
been identified as doomed at the 12-month 
convalescence markS and might have been 
saved by earlier consideration of retrans-
plantation. 
Although the results have slowly im-
proved over the years, the overall percentage 
of 1-year survival rate from 1963 to the 
summer of 1976 was only 35 per cent. By 
this time the technical and management im-
provements described earlier had been com-
pleted. From then until December 1977, the 
I-year survival rate in pediatric recipients 
was 62 per cent. 
The results in patients with..hiliary atresia 
were inferior to those with other diagnoses 
(Table 4+-2). a 33 per cent versus a 50 per 
cent I-year survival rate. The difficulties in 
patients with atresia were ascribable in part 
to technical difficulties of anastomosing 
small structures, problems that can be large-
ly circumvented with microvascular tech-
niques. Avoidance of patients with complex 
additional anomalies should also improve 
the record. 
The quality of life achieved by long-term 
survivors is a particularly important issue in 
pediatric patients. A detailed study of this 
question in all our patients has been made. S 
It was mentioned earlier that the patients 
who died late were often identifiable by 12 
months as unsatisfactory, haVing either poor 
liver function or dangerously high steroid 
requirements. This was reflected in hospital-
ization times that exceeded 50 per cent both 
TABLE 44-2 ONE-YEAR AND LATER SURVIVAL 
WITH BILIARY ATRESIA VERSUS OTHER 
DISEASES 
1-V •• , Survlv.' Now 
Numb., Survlv.. (1-' V ..... , 
Biliary atresia 48 
Other diseases 26 
16 (33%) 
13 (50%) 
8 (17'11.) 
8 (31'11.) 
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in the first year and afterward until the 
deaths of the patients. Almost all of the 
infants in this failed group created severe 
domiciliary problems for their parents. Of 
the preadolescents and teen-agers, only a 
few returned to school or work for signifi-
cant periods of time. The best rehabilitation 
was in two patients who had an excellent 
clinical result at 1 year after treatment. A 
4-year-old child was well for 3 years but 
sustained crippling liver and renal damage 
after a Hemophilus infection and died sever-
al weeks later. His homograft had chronic 
rejection. Another patient died from biliary 
tract complications and chronic rejection 6 
years after transplantation for Wilson's dis-
ease. 
In contrast to those who died after 1 year, 
the 16 patients who are still alive had an 
identifiably good prognosis at 12 months. At 
the 1-year mark. none were jaundiced and 
the average prednisone doses were reason-
able. Although they spent about a third of 
their time in the hospital during the first year 
posttransplantation, they ultimately became 
independent of the institution. and after the 
first 12 months they have been hospitalized 
an average of less than 3 per cent of the time. 
The adolescents and children have been in 
public or special schools. Many of the chil-
dren who were infants at the time of trans-
plantation eventually became students. 
These children with good clinical results 
have tended to remain small as a result of 
long-term steroid therapy, but they have 
achieved steady growth. 
Selected References 
Perusal of the five references below will provide a 
nearly complete picture of the history and present state 
of liver transplantation. Scholars interested in original 
publications will be able to track these easily. especially 
in reference 3. Reference 5 is the most recently written. 
with a bibliography that is current to January 1979. 
1. Caine. R. Y .• and Williams. R.: Liver transplantation. 
In Ravitch. M. M. (ed.): Current Problems In 
~ Surgery. Chicago. Year Book Medical Publish-
ers. 1979, pp. 3-44. 
The important clinical series of 74 cases from 
the Cambridge-Kings College London group are 
described, as well as laborotory research in 
these institutions. Although almost all of the 
recipients were adults. the opinions expressed 
have applicability to pediatric cases. Opinions 
about patient selection. biliary troct reconstruc· 
tion. ond immunosuppression are somewhat 
different from those expressed in this chapter. 
2. Fortner. J. G .. Yeh. S. D. J., Kim. D. K .• Shu!. M. H., 
and Kinne. D. W.: The case for technique of 
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heterotopic liver grafting. Transplant. Proc .. 11 : 
269-275. 1979. 
This coJ/eelion of 43 clinical auxiliary liver 
transplantation cases from many differenl 
centers was presented to the International 
Transplantation Society in Rome. September. 
1978. The case for auxiliary transplantation is 
presenled optimistically. perhaps excessively so 
in vie\\' of the poor results. 
3. Starz!. T. E. (with the assistance of Putnam. C. W.J: 
Experience in Hepatic Transplantation. Phila-
delphia. W. B. Saunders Company. 1969. pp. 1-
553. 
This text contains the total world Iiferature 
(299 references) on experimental and clinical 
liver transplantation to the spring of 1969. an 
account of all 42 human liver homotransplanta-
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